TaiGen Biotechnology Company Ltd. is a research-based and product-driven biopharmaceutical company based in Taiwan. The company focuses on the discovery, development and commercialization of drugs for use in oncology and in the treatment of immune disorders and infectious diseases. Under the leadership of an executive team with decades of experience in major international pharmaceutical and biotech companies and with a talented R&D staff, TaiGen is positioned to become a top global pharmaceutical company and a leader in Asia. TaiGen currently has operations in Taiwan, China, and the U.S.
TaiGen was founded in May 2001. In February 2002, TaiGen opened its state-of-the-art 40,000 square foot corporate R&D facility in Taiwan’s Nei-hu industrial park, which is in the center of a cluster of top research institutes.